There's new uncertainty about updated COVID-19 shots this fall after the Trump administration's handling of a shot from ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

HealthDay News — On Tuesday, the US Department of Health and Human Services announced that the government will invest $176 million in Moderna to expedite the creation of a pandemic influenza vaccine, ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Under emergency use, vaccines can be removed even after a health emergency is considered to be over. Full approval from the FDA means a product can stay on the market even after a health emergency ...

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

Father-of-three James Giddings has a rare allergy to a chemical so common it is in everything from soap and shaving gel to shampoo, toothpaste and even the coating on ibuprofen tablets.

BUT BEFORE I LET YOU GO, ONE LAST QUESTION ABOUT VACCINE. AND THIS IS COVID. SO, YOU KNOW, WE’VE TALKED ABOUT THAT AT NAUSEUM FOR THE LAST, WHAT, FIVE YEARS. PROTECTION WANES OVER TIME.

Lawyer Aaron Siri filed the FOIA lawsuits, on behalf of the nonprofit Public Health and Medical Professionals for Transparency, in 2021 and 2022 against the FDA to obtain records related to Pfizer’s ...